BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15254762)

  • 1. Expression of CD34-positive sinusoidal endothelial cells in patients with HBV-associated chronic liver diseases.
    Ohmori S; Shiraki K; Sugimoto K; Yamanaka Y; Yamaguchi Y; Saitou Y; Fujikawa K; Murata K; Nakano T
    Int J Mol Med; 2004 Aug; 14(2):179-84. PubMed ID: 15254762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.
    Ohmori S; Shiraki K; Sugimoto K; Sakai T; Fujikawa K; Wagayama H; Takase K; Nakano T
    Hum Pathol; 2001 Dec; 32(12):1363-70. PubMed ID: 11774170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
    Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
    Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma.
    Lee ES; Han EM; Kim YS; Shin BK; Kim CH; Kim HK; Won NH; Yeom BW; Kim I; Leong AS
    Am J Clin Pathol; 2005 Jul; 124(1):31-6. PubMed ID: 15923163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.
    Pusztaszeri MP; Seelentag W; Bosman FT
    J Histochem Cytochem; 2006 Apr; 54(4):385-95. PubMed ID: 16234507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
    Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
    Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced generation of endothelial cells from CD34+ cells of the bone marrow in rheumatoid arthritis: possible role in synovial neovascularization.
    Hirohata S; Yanagida T; Nampei A; Kunugiza Y; Hashimoto H; Tomita T; Yoshikawa H; Ochi T
    Arthritis Rheum; 2004 Dec; 50(12):3888-96. PubMed ID: 15593185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
    Ruck P; Xiao JC; Kaiserling E
    Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
    Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M
    Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinoma.
    Yao DF; Wu XH; Su XQ; Yao M; Wu W; Qiu LW; Zou L; Meng XY
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):381-6. PubMed ID: 16911935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.